Cempra: Why This Small-Cap Biotech May Soar Soon [Seeking Alpha]
CEMPRA (CEMP)
US:NASDAQ Investor Relations:
ir.melinta.com/investor-relations
Company Research
Source: Seeking Alpha
Summary Cempra, Inc. (NASDAQ: CEMP ) is an American, clinical-stage biotechnology company focused on developing anti-infectives for the acute care and communal diseases sectors. Cempra was founded in 2006 and is headquartered in Chapel Hill, N.C. Its 2 lead products in the pipeline are Solithromycin, which is in Phase III trials for the treatment of bacterial pneumonia in adults and children, and Fusidic Acid, also in Phase III for the treatment of bacterial skin infections. Recent trial results for the latter drug have been positive on both effectiveness and safety concerns . Obviously these are huge markets, and Cempra's products have an edge over competitors due to their wide range of distributive options. Cempra also has a third drug, Taksta, which is set to read out Phase III results sometime this quarter...so any day now. Shares of CEMP were hit hard late last year on an not entirely unexpected FDA rejection, but the concerns were more about the supplier Cempra w
Show less
Read more
Impact Snapshot
Event Time:
CEMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CEMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CEMP alerts
High impacting CEMPRA news events
Weekly update
A roundup of the hottest topics